Docking studies of 1,5-diarylimidazole COX-2 inhibitors

被引：0

作者：

Li, Shun-Lai ^{[1
]}

Zheng, Yan ^{[1
]}

Wang, Feng-Ying ^{[1
]}

机构：

[1] School of Science, Beijing University of Chemical Technology, Beijing 100029, China

来源：

Beijing Huagong Daxue Xuebao (Ziran Kexueban)/Journal of Beijing University of Chemical Technology (Natural Science Edition) | 2006年 / 33卷 / 04期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The structures of a new series of cyclooxygenase-2 inhibitors, comprising 29 different 1, 5-diarylimida-zoles, were optimized using PM5 semiempirical quantum chemical methods. Docking of these inhibitors with the active site in COX-2 was investigated using the Dock into Active Site method. It was found that the structures of the 1, 5-diarylimidazole COX-2 inhibitors are similar to the structures of typical tricyclic selective COX-2 inhibitors, and the inhibitory activities lg(IC50) are correlated with docking free energies.

引用

页码：75 / 79

共 50 条

[31] Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors
Eren, Goekcen
Unlu, Serdar
Nunez, Maria-Teresa
Labeaga, Luis
Ledo, Francisco
Entrena, Antonio
Banoglu, Erden
Costantino, Gabriele
Sahin, M. Fethi
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) : 6367 - 6376
[32] Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors
Kaya Cavusoglu, Betul
Saglik, Begum N.
Acar Cevik, Ulviye
Osmaniye, Derya
Levent, Serkan
Ozkay, Yusuf
Kaplancikli, Zafer A.
ARCHIV DER PHARMAZIE, 2021, 354 (03)
[33] Design, synthesis and biological evaluation of new tricyclic spiroisoxazoline derivatives as selective COX-2 inhibitors and study of their COX-2 binding modes via docking studies
Hoda Abolhasani
Siavoush Dastmalchi
Maryam Hamzeh-Mivehroud
Bahram Daraei
Afshin Zarghi
Medicinal Chemistry Research, 2016, 25 : 858 - 869
[34] Synthesis, biological evaluation and molecular docking studies of stellatin derivatives as cyclooxygenase (COX-1, COX-2) inhibitors and anti-inflammatory agents
Gautam, Raju
Jachak, Sanjay M.
Kumar, Vivek
Mohan, C. Gopi
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1612 - 1616
[35] NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties
Chegaev, Konstantin
Lazzarato, Loretta
Tosco, Paolo
Cena, Clara
Marini, Elisabetta
Rolando, Barbara
Carrupt, Pierre-Alain
Fruttero, Roberta
Gasco, Alberto
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) : 1449 - 1457
[36] Synthesis of 1,5-Diarylpyrazoles as Potential COX-2 Inhibitors with Nitric Oxide Releasing Ability
Rao, Bolla Narasimha
Muthuppalaniappan, Meyyappan
Dinavahi, Saketh Sriram
Viswanadha, Srikant
Bagul, Chandrakant
Srinivas, Kolupula
Vakkalanka, Swaroop Kumar V. S.
Atcha, Krishnam Raju
Kamal, Ahmed
LETTERS IN DRUG DESIGN & DISCOVERY, 2013, 10 (07) : 594 - 603
[37] Molecular Docking and dynamic simulation analysis of flavonoid derivatives as COX-2 inhibitors
Pasula Janakiramulu
Estari Mamidala
In Silico Pharmacology, 13 (2)
[38] New indomethacin analogs as selective COX-2 inhibitors: Synthesis, COX-1/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies
Abdellatif, Khaled R. A.
Abdelall, Eman K. A.
Elshemy, Heba A. H.
El-Nahass, El-Shaymaa
Abdel-Fattah, Maha M.
Abdelgawad, Yasmin Y. M.
ARCHIV DER PHARMAZIE, 2021, 354 (04)
[39] COX-1/COX-2 inhibitors based on the methanone moiety
Dannhardt, G
Fiebich, BL
Schweppenhäuser, J
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (02) : 147 - 161
[40] Nimesulide and COX-2 inhibitors
Bakhle, YS
LANCET, 1999, 354 (9180): : 772 - 772

← 1 2 3 4 5 →